ARTICLE SYNOPSIS...Pfizer has been underperforming for many years. But now there are signs the stock could see a bullish makeover.
ARTICLE SYNOPSIS...Statistical analysis is used to show that Pfizer is in the process of reversing its intermediate-term trend from up to down.